Al-Dawaa Medical Services Company

TADAWUL:4163.SR

95 (SAR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 1,586.2721,516.421,458.0871,438.9461,436.7391,407.5921,458.31,308.931,310.1911,294.8211,298.3411,259.5581,266.7681,209.7151,240.9291,240.9291,303.8371,240.109
Cost of Revenue 1,010.301951.997932.998918.035911.097872.615924.61823.986803.402800.646765.257808.172808.79757.758803.898803.898773.076751.562
Gross Profit 575.971564.423525.09520.911525.642534.976533.69484.944506.789494.175533.084451.386457.977451.956437.031437.031530.762488.547
Gross Profit Ratio 0.3630.3720.360.3620.3660.380.3660.370.3870.3820.4110.3580.3620.3740.3520.3520.4070.394
Reseach & Development Expenses 000000000000000000
General & Administrative Expenses 33.78635.385-54.26934.29826.13635.574-42.30428.08534.44931.989-47.09535.89836.68626.07223.71623.71628.28327.735
Selling & Marketing Expenses 405.877396.263-919.141384.622377.465384.438-935.678374.172381.788391.472-862.92364.681354.379351.534325.89325.89370.819349.244
SG&A 439.664431.648-973.41418.921403.601420.012-977.982402.257416.237423.461-910.015400.579391.066377.606353.675353.675399.101376.979
Other Expenses -441.673-433.93-397.3951.751-0.298-0.139-7.674-0.5713.2764.304-13.620.9792.561.9760000
Operating Expenses 441.673433.93397.395418.921403.601420.012403.297402.257416.237423.461452.118400.579391.066377.606292.723292.723456.78431.454
Operating Income 134.298130.493127.695101.99122.041114.964125.08582.68790.55270.71475.82450.80766.91174.35183.35783.357131.66111.568
Operating Income Ratio 0.0850.0860.0880.0710.0850.0820.0860.0630.0690.0550.0580.040.0530.0610.0670.0670.1010.09
Total Other Income Expenses Net -134.298-130.493-127.695-28.172-28.447-35.179-30.151-31.533-7.88118.395-8.876-10.014-10.4727.4874.4614.461-72.31-68.839
Income Before Tax 103.91398.79395.20673.81993.59479.78594.93451.15482.67289.10966.94840.79456.43981.83787.81787.81759.35142.73
Income Before Tax Ratio 0.0660.0650.0650.0510.0650.0570.0650.0390.0630.0690.0520.0320.0450.0680.0710.0710.0460.034
Income Tax Expense 8.0353.4652.8552.5354.263.535.421322-2.1272.53.533.8293.82943.5
Net Income 95.87895.32892.35171.28389.33476.25589.51448.15480.67287.10969.07538.29452.93978.83783.98883.98855.35139.23
Net Income Ratio 0.060.0630.0630.050.0620.0540.0610.0370.0620.0670.0530.030.0420.0650.0680.0680.0420.032
EPS 1.131.121.090.841.050.91.050.570.951.020.810.450.620.930.550.553.322.35
EPS Diluted 1.131.121.090.841.050.91.050.570.951.020.810.450.620.930.550.553.322.35
EBITDA 227.992223.038221.258196.325215.98203.801204.612170.579184.572172.325150.451136.677154.26154.89118.263118.263168.315148.223
EBITDA Ratio 0.1440.1470.1520.1360.150.1450.140.130.1410.1330.1160.1090.1220.1280.0950.0950.1290.12